Market Research Industry Today

Novel Ingredients in Infant Formula Market Study Analysis with Forecast to 2034

The novel ingredients in the infant formula market are gaining traction as parents increasingly seek products that closely mimic the nutritional and functional benefits of human breast milk. Ingredients such as HMOs, MFGM, advanced prebiotics, probiotics, and bioengineered proteins are being incorporated to support immunity, digestion, and cognitive development. Rising health concerns, including allergies and digestive issues in infants, are driving demand for specialized and premium formulas.
Published 20 November 2025

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the Novel Ingredients in Infant Formula Market”-, By Product Type (Plant-Based Milk, Plant-Based Juices, RTD Tea & Coffee, Others), By Source (Nuts, Grains, Legumes, Fruits & Vegetables, Others), By Distribution Channel (Online, Offline), and Global Forecasts, 2024-2034 And Segment Revenue and Forecast To 2034.” 

The Novel Ingredients in Infant Formula Market Size is predicted to grow at 8.7% CAGR during the forecast period for 2025-2034.

 

Request For Free Sample Pages:

https://www.insightaceanalytic.com/request-sample/2977

 

The term "novel ingredients" in infant formula refers to components that exceed the standard nutrients, including protein, fat, carbohydrates, vitamins, and minerals. These innovative substances are added to more closely replicate the composition and potential health benefits of human breast milk. One such ingredient is the Milk Fat Globule Membrane (MFGM), a complex three-layered membrane that surrounds fat droplets in breast milk. MFGM contains a variety of bioactive components, including phospholipids, proteins such as lactoferrin and osteopontin, and cholesterol. Emerging research suggests that these components may play essential roles in supporting brain development, cognitive function, and immune health in infants. Thanks to advancements in extraction technology, MFGM can now be isolated and preserved for inclusion in infant formula. Additionally, novel prebiotics non-digestible food components that selectively stimulate the growth and activity of beneficial gut bacteria are being added to formulas. Examples include galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS), which help promote a healthy gut microbiome and enhance overall infant well-being.

There is a growing demand for infant formulas enriched with functional ingredients that support key areas of development such as immunity, digestion, and cognitive function. This trend is especially prominent in the specialty formula segment, which is tailored to meet the unique health needs of certain infants. The incorporation of prebiotics, probiotics, and postbiotics is becoming increasingly common, as these components play a vital role in fostering a healthy gut microbiome and strengthening the immune system. At the same time, advancements in biotechnology have made it possible to produce novel ingredients like human milk oligosaccharides (HMOs) and milk fat globule membrane (MFGM), which closely resemble critical components of human breast milk. These innovations are significantly enhancing the nutritional value and functionality of modern infant formulas.

List of Prominent Players in the Novel Ingredients in Infant Formula Market:

·      DSM

·      FrieslandCampina

·      Novonesis (Chr. Hansen + Novozymes)

·      DuPont (IFF Nutrition)

·      BASF

·      AAK

·      Glycosyn

·      Inbiose

·      Kyowa Hakko

·      Nestlé

·      Danone (Nutricia)

·      Abbott Nutrition

·      Reckitt (Mead Johnson)

·      Arla Foods

·      Fonterra

·      Helaina

·      Biomilq

·      108LABS

·      Turtletree Labs

·      Else Nutrition

·      ByHeart

·      Sprout Organic

·      Conagen

·      Nature’s One

·      Bactolife

·      Evonik

·      Glycotope

Market Dynamics:

Drivers:

The increasing focus on infant health and optimal early-life nutrition is a major factor propelling the demand for novel ingredients in infant formula. Today’s consumers are more informed and health-conscious, leading to greater preference for premium formulas enriched with advanced components such as HMOs, MFGM, and bioengineered proteins that support immunity, digestive health, and cognitive development. Additionally, the rising incidence of food allergies, gastrointestinal disorders, and metabolic conditions among infants is fueling the demand for specialized and hypoallergenic formulations. 

 

Curious about this latest version of the report? @

https://www.insightaceanalytic.com/enquiry-before-buying/2977

Challenges:

A significant challenge for the industry is the complex and time-consuming regulatory approval process. Novel ingredients must undergo stringent safety and efficacy evaluations before being permitted for use in infant formula, which can extend product development timelines. Moreover, the high cost of research, clinical studies, and the specialized manufacturing technologies required for producing these ingredients further adds to the financial and operational burden for manufacturers.

Regional Trends: 

The Asia-Pacific region leads the global infant formula market, supported by factors such as high birth rates, rapid urbanization, and rising household incomes. China remains a major contributor, driven by an expanded retail ecosystem and policy reforms, including the relaxation of the one-child policy. However, declining birth rates and an aging population in China are prompting dairy companies to broaden their portfolios to include adult and elderly nutrition products.

In contrast, North America holds a substantial share of the infant formula ingredients market, backed by supportive government policies and a strong cultural emphasis on infant health and nutrition. The region is characterized by increasing demand for organic, clean-label, and transparently sourced ingredients, reflecting a growing consumer preference for safe, premium-quality nutritional products.

Recent Developments:

·      In April 2025, DSM-Firmenich received approval from the FSSAI to use GLYCARE 2FL, a human milk oligosaccharide, in early-life nutrition products in India.  This comes after the European Commission recently approved dsm-firmenich's HMO ingredient, LNFP-I. The company also just introduced Dry Vit A Palmitate, an early-life nutraceutical intended to treat vitamin A deficiency. Infants can now use the component 2'-O-Fucosyllactose (2'-FL), with a daily maximum suggested intake of 1.2 grams per liter of formula.

·      In Oct 2024, dsm-firmenich, Launched Dry Vit A Palmitate for Early Life Nutrition, a ground-breaking clean-label solution created to improve the nutritional value of newborn formulae without the stability problems associated with conventional vitamin A components, was announced by leaders in health, nutrition, and beauty.

·      In Sep 2023, Danone, the head of Danone's early life nutrition division and vice president announced a new newborn formula in China that contains milk droplets that closely resemble the structure of mothers' milk, according to Growth Asia.

 

Get Specific Chapter/Information From The Report:

https://www.insightaceanalytic.com/customization/2977

 

Segmentation of Novel Ingredients in Infant Formula Market.

Global Novel Ingredients in Infant Formula Market - By Ingredient Type

·      Human Milk Oligosaccharides (HMOs)

·      Milk Fat Globule Membrane (MFGM)

·      Synthetic/Bioengineered Proteins

·      Next-Gen Probiotics

·      Plant-Based Bioactives

·      Glycomacropeptides (GMPs)

·      Exosomes and MicroRNAs

Global Novel Ingredients in Infant Formula Market – By Application

·      Standard Infant Formula

·      Follow-On Formula

·      Specialty Formula

·      Growing-Up Milk

Global Novel Ingredients in Infant Formula Market – By Source

·      Bioengineered

·      Plant-Based

·      Animal-Derived

Global Novel Ingredients in Infant Formula Market – By Region

North America-

·      The US

·      Canada

Europe-

·      Germany

·      The UK

·      France

·      Italy

·      Spain

·      Rest of Europe

Asia-Pacific-

·      China

·      Japan

·      India

·      South Korea

·      Southeast Asia

·      Rest of Asia Pacific

Latin America-

·      Brazil

·      Argentina

·      Mexico

·      Rest of Latin America

 Middle East & Africa-

·      GCC Countries

·      South Africa

·      Rest of the Middle East and Africa

 

Get More Information @

https://www.insightaceanalytic.com/report/novel-ingredients-in-infant-formula-market/2977


About Us:

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.

Contact Us:

info@insightaceanalytic.com

InsightAce Analytic Pvt. Ltd.

Visit: www.insightaceanalytic.com

Tel : +1 607 400-7072

Asia: +91 79 72967118

Follow Us on LinkedIn @ bit.ly/2tBXsgS

Follow Us On Facebook @ bit.ly/2H9jnDZ

Twitter: https://twitter.com/Insightace

Other Industry News

Ready to start publishing

Sign Up today!